Invus Public Equities, L.P.'s Net Worth
$50.9 Million
Who is Invus Public Equities, L.P.?
Invus Public Equities, L.P. has an estimated net worth of $50.9 Million. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Seer, Inc., Generation Bio Co., LEXICON PHARMACEUTICALS, INC., ANTIGENICS INC /DE/, SQZ Biotechnologies Co, Scholar Rock Holding Corp, GLYCOMIMETICS INC, Furiex Pharmaceuticals, Inc., and NITROMED INC.
SEC CIK
Invus Public Equities, L.P.'s CIK is 0001340097
Past Insider Trading and Trends
2023 was Invus Public Equities, L.P.'s most active year for acquiring shares with 12 total transactions. Invus Public Equities, L.P.'s most active month to acquire stocks was the month of January. 2020 was Invus Public Equities, L.P.'s most active year for disposing of shares, totalling 8 transactions. Invus Public Equities, L.P.'s most active month to dispose stocks was the month of July. 2020 saw Invus Public Equities, L.P. paying a total of $37,650,000.00 for 10,261,410 shares, this is the most they've acquired in one year. In 2021 Invus Public Equities, L.P. cashed out on 5,252,545 shares for a total of $16,201,519.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LEXICON PHARMACEUTICALS, INC. (LXRX) Snapshot price: $1.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +73.18% | 57.55M |
—
|
—
| 136.18M |
May 10
| |||
Form 4
|
∞
| 1.15M |
$108.50 | $124,875,037.00 | 1.15M |
Mar 13
| |||
Form 4
| +54.61% | 27.78M |
$2.60 | $72,215,130.00 | 78.63M |
Jun 5
| |||
Form 4
| +5.01% | 2.43M |
$2.50 | $6,065,175.00 | 50.86M |
Aug 5
| |||
Form 4
| +50.14% | 16.17M |
$2.50 | $40,434,500.00 | 48.43M |
Aug 1
| |||
Form 4
| +51.30% | 10.94M |
$3.20 | $35,000,000.00 | 32.26M |
Dec 16
| |||
Form 4
| +5.49% | 182.84K |
$12.51 | $2,287,376.72 | 3.52M |
Jun 27 - Jun 28
| |||
Form 4
| +8.24% | 253.72K |
$12.99 | $3,295,173.13 | 3.33M |
Jun 22 - Jun 25
| |||
Form 4
| +2.43% | 72.97K |
$13.29 | $970,045.19 | 3.08M |
Jun 19 - Jun 21
| |||
Form 4
| +1.55% | 45.78K |
$12.98 | $594,398.91 | 3.01M |
Jun 14 - Jun 18
| |||
Form 4
| +8.64% | 235.4K |
$12.80 | $3,014,123.06 | 2.96M |
Jun 8 - Jun 12
| |||
Form 4
| +13.57% | 325.64K |
$12.58 | $4,095,065.19 | 2.73M |
Jun 5 - Jun 7
| |||
Form 4
| +21.00% | 416.48K |
$12.01 | $5,002,666.67 | 2.4M |
May 31 - Jun 4
| |||
Form 4
| +27.96% | 433.38K |
$9.94 | $4,306,418.18 | 1.98M |
May 25 - May 30
| |||
Form 4
| +13.20% | 180.73K |
$10.11 | $1,826,895.85 | 1.55M |
Nov 15 - Nov 17
| |||
Form 4
| +72.60% | 575.95K |
$9.64 | $5,554,165.52 | 1.37M |
Nov 10 - Nov 14
| |||
Form 4
|
∞
| 149.25M |
$1.01 | $149,999,999.65 | 149.25M |
Nov 26
| |||
Form 4
| +1.07% | 3M |
$2.25 | $6,750,000.00 | 283.15M |
Oct 23
| |||
Form 4
| +81.61% | 115M |
$1.13 | $129,954,799.11 | 255.93M |
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANTIGENICS INC /DE/ (AGEN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NITROMED INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.99M |
$0.86 | -$4,283,077.10 |
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.85% | -322.36K |
$0.19 | -$61,206.32 | 6.32M |
Aug 7 - Aug 8
| |||
Form 4
| -3.21% | -220.25K |
$0.19 | -$41,183.94 | 6.64M |
Aug 5 - Aug 6
| |||
Form 4
| -16.06% | -1.38M |
$0.23 | -$315,261.62 | 7.21M |
Jul 26 - Jul 30
| |||
Form 4
| +1.18% | 100K |
$1.70 | $170,000.00 | 8.59M |
Feb 24
| |||
Form 4
| +4.94% | 400K |
$1.78 | $712,255.00 | 8.49M |
Feb 21 - Feb 23
| |||
Form 4
| +23.05% | 1.52M |
$2.00 | $3,027,928.63 | 8.09M |
Feb 15 - Feb 17
| |||
Form 4
| +0.17% | 11.45K |
$3.24 | $37,123.00 | 6.57M |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $1.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.27M |
$16.93 |
—
| 2.27M |
Jul 30 - Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||